As expected, we confirmed that the epithelial marker E-Cadherin was downregulated, while the mesenchymal marker Vimentin was upregulated after PCa cells were treated with LNCaP-Bic and LNCaP-AI exosomes (Fig. 2J, K). The gene discussed is VIM; the disease is posterior cortical atrophy.